Free Trial

This company has been marked as potentially delisted and may not be actively trading.

4D pharma (LBPS) News Today

Human Microbiome Market Report 2023-2033
Expert Ratings for 4D Molecular Therapeutics
X4 Pharmaceuticals: Upcoming Catalysts
4D pharma reports FY results
ACHR,EBON and GENI among pre market gainers
Get 4D pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPS and its competitors with MarketBeat's FREE daily newsletter.

LBPS Media Mentions By Week

LBPS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LBPS
News Sentiment

0.00

0.69

Average
Medical
News Sentiment

LBPS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LBPS Articles
This Week

0

0

LBPS Articles
Average Week

Get 4D pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for LBPS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:LBPS) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners